LLY vs CVS
Eli Lilly · CVS Health
| LLY Eli Lilly Healthcare | CVS CVS Health Healthcare | |
|---|---|---|
| Market | ||
| Price | $1,417.54 +3.19% | $90.25 -0.09% |
| Market cap | $1.33T | $115.4B |
| P/E (TTM) | 48.4 | 23.6 |
| Dividend yield | 0.75% | 3.49% |
| 52-week range | $809.63 – $1,408.38 | $69.51 – $110.68 |
| Our research | ||
| Our view | LONG open | LONG open |
| Articles | 1 | 1 |
| Latest article | Eli Lilly (LLY): Two Drugs Drove 88% Of Growth, EPS Hit By $4.57 R&D Oct 31, 2026 | CVS Health's Aetna MBR Just Hit 84.6% — Five Straight Beats Say The Turnaround Is Real (C… Jun 30, 2026 |
| Latest earnings | ||
| Reported | Oct 29, 2026 | Aug 5, 2026 |
| Revenue | $24.4 billion +39% YoY | $106.1 billion +7.3% YoY |
| EPS | $7.22 +7% YoY | $2.31 |
| Guidance | Guidance raised | Guidance raised |
| Revenue growth, last 4 reports | +39% +48% | +7.3% |
| Topics | ||
| Main topics | ||
| Company page · Earnings releases | Company page · Earnings releases | |
Note. Earnings figures are extracted automatically from each company's own release; prices are delayed up to 15 minutes. This comparison is information, not investment advice.